These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29263118)

  • 1. In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum.
    Gunn PJ; Green CJ; Pramfalk C; Hodson L
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism.
    Pramfalk C; Larsson L; Härdfeldt J; Eriksson M; Parini P
    Biochim Biophys Acta; 2016 Jan; 1861(1):51-59. PubMed ID: 26515253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation.
    Huggett ZJ; Smith A; De Vivo N; Gomez D; Jethwa P; Brameld JM; Bennett A; Salter AM
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism.
    Pramfalk C; Jakobsson T; Verzijl CRC; Minniti ME; Obensa C; Ripamonti F; Olin M; Pedrelli M; Eriksson M; Parini P
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158659. PubMed ID: 32058035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
    Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
    Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the temporal, dose, and composition effects of nutritional substrates in an in vitro model of intrahepatocellular triglyceride accumulation.
    Nagarajan SR; Cross E; Johnson E; Sanna F; Daniels LJ; Ray DW; Hodson L
    Physiol Rep; 2022 Oct; 10(20):e15463. PubMed ID: 36301719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
    Sztolsztener K; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
    Biochem Biophys Res Commun; 2021 Dec; 585():132-138. PubMed ID: 34801933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism.
    Nagarajan SR; Paul-Heng M; Krycer JR; Fazakerley DJ; Sharland AF; Hoy AJ
    Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E578-E589. PubMed ID: 30694691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells.
    Vidyashankar S; Sandeep Varma R; Patki PS
    Toxicol In Vitro; 2013 Mar; 27(2):945-53. PubMed ID: 23348005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.
    Lee MR; Park KI; Ma JY
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of the Y220C mutant p53 against steatosis: good news?
    Gori M; Barbaro B; Arciello M; Maggio R; Viscomi C; Longo A; Balsano C
    J Cell Physiol; 2014 Sep; 229(9):1182-92. PubMed ID: 24395441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2).
    Arrol S; Mackness MI; Durrington PN
    Atherosclerosis; 2000 Jun; 150(2):255-64. PubMed ID: 10856517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers.
    Steenbergen RH; Joyce MA; Thomas BS; Jones D; Law J; Russell R; Houghton M; Tyrrell DL
    Hepatology; 2013 Dec; 58(6):1907-17. PubMed ID: 23775894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute-on-chronic effects of fatty acids on intestinal triacylglycerol-rich lipoprotein metabolism.
    Black IL; Roche HM; Tully AM; Gibney MJ
    Br J Nutr; 2002 Dec; 88(6):661-9. PubMed ID: 12493088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.
    Gori M; Simonelli MC; Giannitelli SM; Businaro L; Trombetta M; Rainer A
    PLoS One; 2016; 11(7):e0159729. PubMed ID: 27438262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.